This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.
|
|
- Wilfrid Parker
- 6 years ago
- Views:
Transcription
1 This is controlled document. The mster document is posted on the JRCO wesite nd ny print-off of this document will e clssed s uncontrolled. Reserchers nd their tems my print off this document for trining nd reference purposes ut re responsile for regulrly checking the JRCO wesite for more recent versions Joint Reserch Audit SOP SOP Reference: JRCO/SOP/018 Version Numer: 7.0 Effective Dte: 25 Oct 2017 Review y: 25 Oct 2020 Author: Gisel Brreto, Clinicl Trils Mnger Approved y: Gry Roper Dte: 24 Oct 2017 Version Dte Reson for Chnge Version My 2007 Annul review Version Jun 2008 Annul review Version Fe 2010 Formtion of Joint Reserch Office Version Jul 2011 Annul Review Version Nov 2012 Annul Review Version Fe 2015 Scheduled Review Version Aug 2017 Scheduled Review V Oct 2017 Pge 1 of 21
2 Tle of Contents 1. Purpose Pge 3 2. Introduction Pge Audit Requirement Pge Role of the Auditor Pge 4 3. Procedure Pge Auditor Qulifictions Pge Selection Process Pge Studies/Site Selection Pge Smpling Frme Pge Systems Prioritistion Pge Audit Pln Pge Physicl Audit Process Pge Audit Findings Pge Audit Results Pge Finl Audit Progrmme Pge9 3.8 Follow-up ctions Pge Escltion Process nd Conflict Resolution Pge 9 4. References Pge Appendices 5.1 Audit Pln Templte 5.2 Audit Tool Templte 5.3 Audit Report Templte Pge 11 Pge 11 Pge 13 Pge 23 V Oct 2017 Pge 2 of 21
3 1. PURPOSE This SOP descries the udit procedures of the Imperil College Acdemic Helth Science Centre (AHSC) s Joint Reserch (JRCO), cting on ehlf of Imperil College nd Imperil College Helthcre NHS Trust s Sponsor orgnistions. This SOP specificlly descries the processes for selecting those studies for udit tht fll under the Deprtment of Helth Reserch Governnce Frmework for Helth nd Socil Cre 2005 (2 nd Edition) nd/or the Medicines for Humn Use (Clinicl Trils) Regultions 2004 nd susequent mendments; the procedures for crrying out udits; nd reporting udit results to Investigtors. This SOP lso descries the requirements for Investigtors to respond to JRCO udit reports nd implement corrective ctions. Hosted Studies will not e udited y the JRCO ut sponsors will e requested to supply copies of ny udit reports of hosted studies where sitution of risk to ptients sfety, serious non-complince or dt integrity wrrnt it. 2. INTRODUCTION As legl Sponsor orgnistion (n institution tht tkes responsiility for initition, mngement nd/or finncing of clinicl tril), Imperil College AHSC s JRCO, representing Imperil College London nd Imperil College Helthcre NHS Trust, is responsile for uditing reserch prctice nd ssuring dherence to current legisltion nd guidelines s prt of qulity mngement system. As such, it is necessry to udit reserch for which Imperil College AHSC is the led Sponsor ginst the stndrds of the Reserch Governnce Frmework 2005 (2nd Edition) nd the Medicines for Humn Use (Clinicl Trils) Regultions 2004 where pplicle nd ginst the qulity systems of Good Clinicl Prctice intrinsic to the Regultions. This guidnce is to ssist reserchers in understnding the udit process, so tht they re prepred should they volunteer or e selected for internl udit. The purpose of reserch udit is to: Ensure prticipnt nd stff sfety Ensure prticipnt rights, welfre nd well-eing re eing dequtely protected. Evlute tril conduct nd ensure reserchers complince with the protocol, SOPs, GCP nd the regultory requirements nd Trust nd College policy Improve reserch systems nd dt qulity Prepre reserchers for externl udit processes Demonstrte roust reserch processes to externl funders nd industry 2.1 Audit requirement Under the Reserch Governnce Frmework nd the Medicines for Humn Use (Clinicl Trils) Regultions 2004, the Sponsor is responsile for the mngement nd monitoring of study. The JRCO is responsile for uditing reserch on ehlf of Imperil College AHSC. Projects will e udited: On voluntry sis As result of risk grded ssessment (routine udit) If there is suspicion of significnt non-complince to regultion (For-cuse udit) V Oct 2017 Pge 3 of 21
4 A written report on study progression does not constitute udit nd should e sumitted for every study in ddition to udit requirements. For detiled description on the risk ssessment process plese refer to JRCO/SOP/ Role of the uditor It is the uditor s primry role to collect evidence of reserch prctice nd compre it ginst the requirements of Good Clinicl Prctice nd Reserch Governnce. The uditor is responsile for documenting oservtions nd conclusions, sfegurding udit documents, records nd reports, ssessing whether requirements re eing met, nd developing reports incorporting recommendtions for chnge or dherence. 3. PROCEDURE 3.1 Auditor Qulifictions The uditor should e independent to the reserch tem/reserch systems to conduct udits ppropritely. An uditor should e qulified y trining nd experience to conduct udits properly. An uditor s qulifictions should e documented (ICH GCP ). 3.2 Selection Process Studies/sites The selection process should tke into ccount the importnce of the reserch project in respect to regultory sumissions, e.g. is it registrtion tril, the type nd complexity of the study, the perceived level of risk to the prticipnts, the numer of ptients to e enrolled nd ny identified prolem (ICH GCP ). A risk sed smpling frme should e used for selecting studies for uditing. Studies cn lso e selected d hoc, trgeted sed on emerging issues Smpling frme Audits of sponsored studies/sites will follow risk-sed pproch. During the sponsorship process studies will e risk ssessed ccording to JRCO/SOP/009. Studies re ssessed ccording to the risk ssessment tool V4 (this uses common formul sed on severity nd likelihood of risks tht impct on ptient/suject welleing/orgnistion nd integrity of dt) nd divided into 5 risk ctegories/severity: Ctstrophic 5 Mjor 4 Significnt 3 Moderte 2 Low 1 V Oct 2017 Pge 4 of 21
5 Ctegory/severity Definition Risk hs severe Risk hs potentil Risk hs little or no potentil hrm to for serious impct if potentil impct on ptients (volunteers) not mnged ptient sfety nd/or integrity of ppropritely on nd/or integrity of dt ptient sfety nd/or integrity of dt dt Routine udits will e performed to prioritise studies within ctegories 5-4 nd 3-2. A docums report will e run to estlish the smple to e udited. The smple will consist of pproved studies nd it will exclude studies in set-up nd those tht hve recently een udited or inspected. Exmple risk fctors for study/progrmme selection Study popultion (e.g. size, vulnerle sujects, new indictions) Product chrcteristics (e.g. new products or with specific risks) Therpeutic re Durtion of study Applicility of regultions (e.g. interntionl vs non-interntionl) Importnce of study to future mrketing sumission (e.g. study phse, pivotl or supporting study) Level of experience of reserch/clinicl tem Confidence in service providers Numer nd nture of outsourcing ctivities nd ssocited interfces for responsiility Level of complexity of study nd trining requirements (e.g. e-system usge/medicl device requirements) Regionl distriution of sites Exmple risk fctors for site selection Numer of sujects per site Numer of protocol devitions Numer of SUSARs/SAE(s) Known complince issues Other spects relevnt to primry study ojectives Efficcy results from site Numer of discontinued sujects Geogrphic loction Level of experience of investigtors nd/or site Level nd nture of monitoring Dt distriution/nomlies/missing dt Multiple vendors oversight cross sites Use of SMO (lone or in comintion with vendor-selected sites) Systems udit - Prioritistion System udits will include numer of studies. The uditor should conduct specific systems or process udits with regulr frequency s defined in the udit progrmme. The selection process for inclusion in the udit progrmme will e risk-sed. The following fctors will e tken into considertion: The importnce of the system/process to (ut not limited to): o Suject sfety or rights (incl. sfety dt reporting) consent process, DSUR process, Dt monitoring committee, Reference Sfety Informtion mngement nd control o Dt integrity review of primry endpoints, monitoring, fit for purposes ssessment of computer systems nd equipment V Oct 2017 Pge 5 of 21
6 Complince with sponsorship procedures o Complince with GCP nd regultions (inc. emerging issues focused on y regultory uthorities) investigtor s complince/oversight, REC sumission process, mngement of Protocol Amendments Degree of process control (e.g. detiled procedures nd controlled documents, level of qulity control pplied y opertionl group, QC/metrics dt, trining) Complince history (e.g. previous udits or inspection findings) Process stility (e.g. new or updted processes) Time since previous udit 3.3 Audit Pln (See Appendix 5.1) An udit pln will e developed y the JRCO Fcilittors nd/or Reserch Governnce Mngers (RGMs)/Clinicl Tril Mnger, nd greed with the resercher involved prior to eginning the udit. The pln should: Define scope nd ojectives for udit Provide timelines for udit conduct Identify where nd when the udit will tke plce Identify requirements to e udited ginst Identify groups nd res to e udited List documents nd records to e studied List responsile people whose functions will e udited Clrify who will get the finl report nd when it will e redy 3.4 Audit Conduct The process will strt y the Reserch Fcilittor nd/or the RGM, explining the scope nd ojectives of the udit, nd how it will e crried out. Exmples of udit techniques include: Interviewing reserchers Reding documents Reviewing mnuls Studying records Reding reports Anlysing dt Oserving ctivity Exmining conditions Confirming interview evidence Documenting oservtions See Appendix 5.2 for the JRCO Audit Tool Templte. V Oct 2017 Pge 6 of 21
7 3.5 Audit Findings Once the prcticl udit hs een completed the Fcilittor/Reserch Governnce Mnger/Tril Mnger will develop summry nd mke preliminry recommendtions to ssist with reserch conduct. The Fcilittor/Reserch Governnce/Tril Mnger will: List ny gps in complince with ny supporting evidence Cross-reference with regultory requirements Grding of findings Audit findings re grded using the following criteri: Criticl: finding defined s one with the cpcity to directly undermine the integrity of the study. It s wekness of, or non-complince with, control process which, if not resolved, will cuse hrm to ptients or dt integrity nd/or orgnistion reputtion tht requires the immedite notifiction nd ttention of senior mngement nd cler timelines for resolution. For exmple findings: Where evidence exists tht the sfety, welleing, rights or confidentility of study sujects hs een (or hs hd significnt potentil to e) jeoprdised. Where reson hs een found to cst serious dout upon the ccurcy nd/or crediility of study dt. Where pprovl for the study hs not een sought from one or more regultory gency/ody or grnted from one or more regultory gency/ody (e.g. Ethics committee, MHRA) ut the study hs commenced regrdless. Where procedures not covered/included on the consent form re eing performed or where new procedures hve een introduced into the study protocol ut where prticipnts who hd consented prior to their introduction hve not een sked to re-consent. Where following study pprovl, significnt mendments hve een mde to the study protocol or documenttion ut no new request for pprovl hs een sumitted. A comintion of multiple mjor udit findings my result in criticl udit finding (if these re in reltion to the sme process or outcome) even though ech of the findings re not criticl. Mjor: finding defined s one tht compromises the integrity of certin component(s) of the study. Wekness of, or non-complince with, control process which, if not resolved, hs the potentil to cuse hrm to ptients or dt integrity nd/or orgnistion reputtion tht requires the timely notifiction nd further investigtion y senior mngement nd cler timelines for resolution. For exmple: Where there hs een filure to comply with the regultory requirements e.g. filure to ssess nd report SAEs nd/or SUSARs ccurtely nd to the correct odies. Where there hs een significnt unjustified deprture from GCP e.g. filure to provide prticipnts with copy of their consent form or Prticipnt Informtion Sheet. V Oct 2017 Pge 7 of 21
8 A comintion of multiple minor udit findings my result in mjor udit finding (if these re in reltion to the sme process or outcome), even though ech of the findings re not mjor. Other/Minor: Any other findings, defined s those where the integrity of the study is not directly compromised ut which represent n sence of due diligence on ehlf of study stff towrds the conduct of the study. Wekness of, or noncomplince with, control process tht currently cuses no hrm to ptients or dt integrity nd/or orgnistion reputtion tht requires resolution. For exmple findings: Which demonstrte tht no definite document mngement/orgnistion processes re in plce t site / no investigtor site file exists. Where there hs een filure y study stff to inform the relevnt uthorities of mendments to strt nd stop dtes or study specific documents. 3.6 Audit Results Where there re mny res of improvement to develop, the Fcilittor nd/or RGM will rrnge meeting with relevnt reserch stff to discuss the recommendtions or gps in complince. This cn e used to develop solutions to ny prolems identified through the udit. 3.7 Finl Audit Report nd Dissemintion Over the following two weeks from initil udit, the Reserch Fcilittor nd/or RGM/CTM will review the gthered informtion nd compile finl report, which will e forwrded to the Hed of Regultory Complince for review. Once the finl report is pproved it will e disseminted to the Chief/Principl Investigtor, the relevnt NHS Trust R&D office, nd stored in the Imperil College AHSC Joint Reserch. The report will include: The detiled udit pln A review of the evidence collected A discussion of ny conclusions drwn from the udit A list of identified gps in complince An ssessment of how well regultory requirements hve een met Recommendtions for chnge in prctice to conform to regultion 3.8 Follow-up ctions It is the Chief Investigtor s responsiility to ensure ction is tken to correct ny identified gps in regultion complince. If ny dvice or ssistnce is required the Reserch Fcilittor/Reserch Governnce Mnger/Clinicl Trils Mnger will e le to help with this. The Chief Investigtor of the study is expected to respond to the udit report within 1 month nd corrective ctions mde within timely mnner. V Oct 2017 Pge 8 of 21
9 3.9 Escltion process nd conflict resolution In the fce of ny dispute the reports nd findings/grding will e reviewed in ccordnce with the Joint Reserch (JRCO) escltion policy. The elow digrm provides the escltion route: Imperil College London Helthcre NHS Trust Bord nd Imperil College London Bord Fculty Den Fculty Operting Officer ICL Director of Reserch ICL Hed of Regultory Complince Reserch Governnce Mnger/Clinicl Trils Mnger Reserch Fcilittor V Oct 2017 Pge 9 of 21
10 4. REFERENCES Deprtment of Helth Reserch Governnce Frmework for Helth nd Socil Cre 2005 (2 nd Edition). UK Clinicl Trils (Medicines for Humn Use) Regultions 2004; ICH GCP E6 (R2) Nov 2016 GCP uditing Principles nd Prctice y RQA NHS R&D Forum. Distinguishing different types of Monitoring nd Audit, Novemer 2008 JRO UK regultions Complince form (Prt 2), version 1.0 NIHR RSS frmework reserch/reserch-support- Service/RSS%20frmework%20docs/Annex%204%20RSS%20NIHR%20Frmework%20 P08%20Oversee%20study.pdf V Oct 2017 Pge 10 of 21
11 5. APPENDICES 5.1 Appendix 1 Audit Pln JRCO Audit Pln Ojectives The ojective of this udit is to ensure complince with <if IMP study> Medicines for Humn Use (Clinicl Trils) Directive 2004, incorporting mendments (2006) from the EU Directive 2005/28/EC on GCP <if non-imp study> Reserch Governnce Frmework for Helth nd Socil Cre, 2 nd edition. For ll studies, we will e looking for dherence to Good Clinicl Prctice s outlined in the ICH Hrmonised Triprtite Guideline for Good Clinicl Prctice (1996). The finl udit report will document findings ginst these guidelines. Project to e udited Project Title JRCO ref PI Type of study Audit site Dte of udit Clinicl tril IMP Audit ojectives Audit smple Audit methods Essentil documents to e ville during the udit ut not limited to: Protocol Consent form nd Prticipnt Informtion Sheets Ethics pprovls nd correspondence Reserch nd Development pprovl nd correspondence JRCO pprovl nd correspondence Regultory pprovls nd correspondence (eg MHRA, GTAC etc) (IMP study only) Generl Study Correspondence (except Trust, Ethics nd Regultory) Trining documents SOPs Dt mngement Serious Adverse Events Phrmcy/Product-Relted (IMP study only) Monitoring nd Audit documenttion Source dt (ie ptient notes) V Oct 2017 Pge 11 of 21
12 Audit Timeline On the dy, the uditor(s) will introduce themselves nd explin the plnned procedure for the dy. It would e useful if seprte room could e orgnised for the uditors to review the documents. For studies tht hve strted recruiting prticipnts, selection of ptient notes should e mde ville for source dt verifiction s per the uditor s selection. Once the udit is complete, the uditor(s) will riefly go through the findings with the study personnel, nd PI if present. A forml report will e provided within two weeks of the udit, with copies sent to the locl R&D office. A response from the PI to the udit findings should e provided within 1 month of receipt of the udit report. V Oct 2017 Pge 12 of 21
13 5.2 Appendix 2 Audit Tool Section 1: Approvls 1 Ethics Approvl Yes No Comments Is there record of full pprovl from REC? Dte: Ref: c d e f If provisionl pprovl, response fully documented? If the REC specified ny mendments/restrictions/conditions to the protocol, were these done/dhered to? If mendments hve een mde were these notified to the REC/HRA/MHRA/Sponsor where pplicle? HRA pprovl HRA pprovl for ll mendments 2 Sponsor Approvl nd Indemnity Does the project hve JRCO pprovl? Dte: If prticipnts re from insurnce-excluded group, hs wiver een pplied for nd ccepted? 3 R&D Approvl Does the project hve R&D pprovl (Cpcity nd Cpility Confirmtion (CCC))? If Trust pprovl ws suject to modifictions eing mde to the reserch design nd protocol, were these mendments mde prior to the project strting? 4 MHRA Approvl Hs full CTA pprovl een received from ech Competent Authority in ech prticipting country? Dte: Dte: EudrCT numer received EudrCT: 5 CAG nd other regultory pprovls not mentioned ove If pplicle, does the study hve pproprite pprovl? CTA ref: Joint Reserch V Oct 2017 Pge 13 of 21
14 6 GTAC Does the study hve GTAC pprovl? Hve SSAs een received for ech ctive locl site? c Flgging project for integrting virl vector studies? 7 JRCO Approvl Does the project hve JRCO pprovl? If JRCO pprovl ws suject to modifictions eing mde to the PIS nd protocol, were these mendments mde prior to the project strting? Section 2: Protocol nd PIS 8 Protocol c Is the finl version of the protocol in the relevnt study file*? Are ll mendments clerly indicted, superseded nd notified to REC/HRA/MHRA where pplicle? Is protocol eing followed ccurtely? 9 PIS, consent nd GP letters c d e f Is the PIS on heded pper with version numer? Is the consent form on heded pper with version numer? Do the PIS nd consent version numers nd dtes mtch? Is consent form in use the ethiclly pproved version? Is there full record of ll reserch prticipnts written informed consent? Hve prticipnts nd resercher completed consent correctly? Yes No Comments V Oct 2017 Pge 14 of 21
15 g h i j k l Is the consent form signed y prticipnt nd resercher on sme, or close dtes (within reson)? Are the consent forms dted y prticipnts nd resercher post pprovls (i.e. ethics/hra, R&D, sponsor, MHRA)? Is copy of the PIS nd consent kept in the ptient notes? Are consented prticipnts eligile? Does the consent form include permission to inform GP? Hs the GP een informed of prticipnt s tking prt in study? m n o p Hs copy of the PIS een given to the reserch prticipnts? Are the consent forms kept in secure loction? Is there full record of ll reserch prticipnts written informed consent? Section 3: Study Conduct 10 Dt Protection If study involves trnsfer of dt to 3 rd prty, is there specific consent? c d e g Are the pper records stored in locked filing cinet? Are electronic files stored on pssword protected computer? If ptient detils re stored on Imperil-networked computers re they nonymised? Does the project meet the Dt Protection Act? If ptients record re ccessed without consent is there pprovl from ECC? 11 Procedures Hve individul study procedures een written? (e.g.: SAE s, Yes No Comments V Oct 2017 Pge 15 of 21
16 tissue, consent, rnd/reg, dt mngement) Is there current study delegtion log? 12 Annul Reports Hve nnul progress reports een sent to REC, Sponsor nd MHRA? 13 Trining c d Do memers of the reserch tem hve individul trining folder Cn they demonstrte knowledge of GCP? Is there current study delegtion log? Are ll study tem memers informed of study nd procedures? 14 IMP studies c d e Is drug ccountility form eing completed (i.e. receipts, dispense, returns re controlled nd documented)? Storge, lelling nd disposl of IMP per Phrmcy instructions? Study listed on pulic Dtse prior to entry of first ptient? EudrCT numer received Hs full CTA pprovl een received from ech Competent Authority in ech prticipnt country? 15 Sfety Reporting c d e Is there record of ll AE s, SAE s nd SUSARs rising during the reserch? Hve nnul DSURs een sent to REC, Sponsor nd MHRA (if pplicle) Hve SUSARS undergone expedited reporting? In protocol, is there list of expected events? Evidence of continued review of sfety of IMP? 16 Tissue studies V Oct 2017 Pge 16 of 21
17 c d e f g h i Is the tissue from recognised tissue nk or hs project-specific ethics pprovl? If tissue is eing stored post ethics-pproved project, is this eing consented to? If tissue is eing stored post ethics-pproved project, is this covered under n pproprite licence from HTA? If genetic nlysis is tking plce, is there pproprite consent? Is the tissue eing used for more thn 1 project? Is the stored tissue nonymised or pseudononymised? Hs the study een logged with the DI for the cmpus? Is there n identified QA person? Is procedure in plce for trcing smples ck to the donor? 17 Steering Committee/Dt Monitoring Does the study hve TSC or DMC? If yes, proof of meetings (minutes) 18 Source Dt Verifiction* *complete monitoring form Does the dt recorded in the CRFs mtch tht recorded in the Source Documents? If there re discrepncies etween the CRFs nd the source dt, hve these een explined nd signed for? *ISF/TMF or other study file s relevnt The ove detils recorded on (<dte>) re correct nd ccurte to the est of my knowledge. Signture of Auditor. Print Nme: V Oct 2017 Pge 17 of 21
18 5.3 Appendix 3 Audit Findings Templte Audit Report Contents Prt A: Visit Detils Prt B: Introduction Prt C: Responses Prt D: Findings Grding of findings Prt E: Comments nd Oservtions Visit findings Prt F: Summry Prt A: Visit Detils Project title JRCO ref PI Type of study Site udited Dte of udit Personnel Present JRCO: Contct detils: Joint Reserch, Acdemic Helth Science Centre, Imperil College London nd Imperil College Helthcre NHS Trust, Room 221, Level 2, Medicl School Building, Norfolk Plce, London, W2 1PG Tel: Emil: Site Stff: Contct detils: V Oct 2017 Pge 18 of 21
19 Prt B: Introduction The purpose of this report is to document the results of the JRCO udit of the ove study nd detil ny findings identified y JRCO stff during the course of the visit. Study findings re divided into three grdes ccording to their seriousness: Criticl, Mjor nd Minor; definition of ech cn e found in section D. You re required to provide the JRCO with response within 1 month of receipt of this report. This response should detil the ctions tht hve een tken to remedy ech of the findings. In the cse of Criticl findings the JRCO my require tht the PI provide evidence tht the recommended ctions hve een tken nd my dditionlly conduct further monitoring visits to re-ssess the site. Findings listed in this report my include references to ICH-GCP (Interntionl Conference on Hrmonistion Good Clinicl Prctice) guideline, the Medicines for Humn Use (Clinicl Trils) Regultions 2004 (SI:1031) incorporting mendments on GCP (SI:1928), Dt Protection Act 1998, the Reserch Governnce Frmework for Helth nd Socil Cre, 2 nd edition. Plese note tht this list is not exhustive. Prt C: Responses Responses should e mde in writing to the JRCO t the ddress ove nd should e sent within 1 month of receipt of this report. Ech finding detiled in this report is numered; the response should list ech finding identified nd detil the ctions tht hve een/will e tken to ddress them. The response should e dted nd should e signed y the Principl Investigtor (PI) for this study. Should the PI or ny memer of site stff feel tht the findings of the visit documented in this report do not ccurtely represent the conduct of the study they my request further consulttion with the JRCO. This request should e mde in writing to the JRCO within two weeks of receipt of this report. The request will need to e signed y the PI, should stte the reson for request nd e directed to those JRCO stff who conducted the originl visit. Upon receipt of the request for consulttion the primry ction of the JRCO will e to confirm receipt nd to schedule meeting etween the PI/site stff nd those memers of the JRCO who conducted the initil visit. The purpose of this meeting will e to discuss the findings of the visit nd scertin where the differences of opinion lie with the im of ultimtely resolving these differences. Prt D: Findings Grding of findings Audit findings re grded using the following criteri: Criticl: A finding defined s one with the cpcity to directly undermine the integrity of the entire study. It s wekness of, or non-complince with, control process which, if not resolved, will cuse hrm to ptients or dt integrity nd/or orgnistion reputtion tht requires the immedite notifiction nd ttention of senior mngement nd cler timelines for resolution. For exmple findings: Where evidence exists tht the sfety, welleing, rights or confidentility of study sujects hs een (or hs hd significnt potentil to e) jeoprdised. Where reson hs een found to cst serious dout upon the ccurcy nd/or crediility of study dt Where pprovl for the study hs not een sought from one or more regultory gency/ody or grnted from one or more regultory gency/ody (e.g. Ethics committee, MHRA) ut the study hs commenced regrdless. Where procedures not covered/included on the consent form re eing performed or where new procedures hve een introduced into the study protocol ut where prticipnts who hd consented prior to their introduction hve not een sked to re-consent. Where following study pprovl, significnt mendments hve een mde to the study protocol or documenttion ut no new request for pprovl hs een sumitted. A comintion of multiple mjor udit findings my result in criticl systemic udit finding even though ech of the findings re not criticl. V Oct 2017 Pge 19 of 21
20 Mjor: finding defined s one tht compromises the integrity of certin component(s) of the study. Wekness of, or non-complince with, control process which, if not resolved, hs the potentil to cuse hrm to ptients or dt integrity nd/or orgnistion reputtion tht requires the timely notifiction nd further investigtion y senior mngement nd cler timelines for resolution. For exmple: Where there hs een filure to comply with the regultory requirements e.g. filure to ssess nd report SAEs nd/or SUSARs ccurtely nd to the correct odies. Where there hs een significnt unjustified deprture from GCP e.g. filure to provide prticipnts with copy of their consent form or Prticipnt Informtion Sheet. A comintion of multiple minor udit findings my result in mjor systemic udit finding, even though ech of the finding re not mjor Minor: Any other findings, defined s those where the integrity of the study is not directly compromised ut which represent n sence of due diligence on ehlf of study stff towrds the conduct of the study. Wekness of, or non-complince with, control process tht currently cuses no hrm to ptients or dt integrity nd/or orgnistion reputtion tht requires resolution. For exmple findings: Which demonstrte tht no definite document mngement/orgnistion processes re in plce t site / no investigtor site file exists. Where there hs een filure y study stff to inform the relevnt uthorities of mendments to strt nd stop dtes or study specific documents. Prt E: Comments nd Oservtions Audit findings During uditing, stff from the JRCO identified findings; of these hve een grded s Criticl, hve een grded s Mjor nd hve een grded s Minor findings. 1. Grde: Criticl Relevnt Guideline(s): Description: Recommended ctions: 2. Grde: Mjor Relevnt Guideline(s): Description: Recommended ctions: Prt F: Summry We will need you to reply to this report within 1 month of receipt nd inform us of wht ctions hve een tken to ddress the findings listed ove. If you hve ny queries plese do not hesitte to contct the JRCO. The ove detils recorded on knowledge. re correct nd ccurte to the est of my V Oct 2017 Pge 20 of 21
21 Signture of Auditor(s). Print Nme: V Oct 2017 Pge 21 of 21
Agilent G6825AA MassHunter Pathways to PCDL Software Quick Start Guide
Agilent G6825AA MssHunter Pthwys to PCDL Softwre Quick Strt Guide Wht is Agilent Pthwys to PCDL? Fetures of Pthwys to PCDL Agilent MssHunter Pthwys to PCDL converter is stnd-lone softwre designed to fcilitte
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationJOB DESCRIPTION. Volunteer Student Teacher. Warwick in Africa Programme. Warwick in Africa Programme Director
JOB DSCRIPTION POST TITL: DPARTMNT: POST RSPONSIBL TO: SALARY: Volunteer Student Techer Wrwick in Afric Progrmme Wrwick in Afric Progrmme Director Voluntry position, ll your costs will be covered (flights,
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationChapter 02 Crime-Scene Investigation and Evidence Collection
Nme: Clss: Dte: Chpter 02 Crime-Scene Investigtion nd Evidence Collection 1. The terms grid, liner, qudrnt, zone, nd spirl re typiclly used to descrie dtum points... Flse Flse 2. An evidence log nd chin
More informationReview TEACHING FOR GENERALIZATION & MAINTENANCE
Gols By the end of clss, you should be ble to: Explin wht generliztion is, why it is criticl for techers to know how to tech so tht it occurs, nd give n exmple of it from your own experience in the clssroom
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationSummary of Package Insert 1
Summry of Pckge Insert 1 For Sttes with Non-Published Policies Indictions Non-infected prtil nd full-thickness skin ulcers due to VSU 2 of greter thn 1 month durtion nd which hve not dequtely responded
More informationBright Futures Medical Screening Reference Table 2 to 5 Day (First Week) Visit
Bright Futures Medicl Reference Tle 2 to 5 Dy (First Week) Visit Universl Action Metolic nd Verify documenttion of neworn metolic screening results, pproprite rescreening, nd needed follow-up. Document
More informationWhangarei District Council Class 4 Gambling Venue Policy
Whngrei Distrit Counil Clss 4 Gmling Venue Poliy April 2013 Whngrei Distrit Counil Clss 4 Gmling Venue Poliy Tle of ontents Introdution... 3 1 Ojetives of the poliy in so fr s promoted y the Gmling At
More informationWORKSHOP FOR SYRIA. A SHORT TERM PROJECT A Collaborative Map proposal Al Moadamyeh, Syria
Al Modmyeh is city locted south-west Dmscus, in Syri. It is fcing post-conflict sitution, fter yers of siege nd displcement of its inhbitnts. Now, the popultion is coming bck, s lso new incomers. Therefore,
More informationCEO MESSAGE STEPHANIE HARVEY. As we take these first steps into the New Year, it s a good time to reflect upon our journey.
2 CEO MESSAGE STEPHANIE HARVEY As we tke these first steps into the New Yer, it s good time to reflect upon our journey. At ICV we re guided by the knowledge tht Aboriginl nd Torres Strit Islnder communities
More informationMay 28, Congressional Requesters
United Sttes Government Accountbility Office Wshington, DC 20548 My 28, 2010 Congressionl Requesters Subject: Federl Funds: Fiscl Yers 2002-2009 Obligtions, Disbursements, nd Expenditures for Selected
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationChapter 5: The peripheral nervous system Learning activity suggested answers
Chpter 5: The peripherl nervous system Lerning ctivity suggested nswers Lerning Activity 5.1 (p. 222) 1 Briefly descrie the two min functions of the somtic nervous system. Description should refer to:
More informationTHE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS
THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS John F. Ptience nd Doug Gillis SUMMARY
More informationSummary. Effect evaluation of the Rehabilitation of Drug-Addicted Offenders Act (SOV)
Summry Effect evlution of the Rehbilittion of Drug-Addicted Offenders Act (SOV) The Rehbilittion of Drug-Addicted Offenders Act (SOV) ws lunched on April first 2001. This lw permitted the compulsory plcement
More informationEffect of linear and random non-linear programming on environmental pollution caused by broiler production
Journl of Novel Applied Sciences Aville online t www.jnsci.org 24 JNAS Journl-24-3-/43-434 ISSN 2322-549 24 JNAS Effect of liner nd rndom non-liner progrmming on environmentl pollution cused y roiler production
More informationNonpharmacologic Interventions for Treatment-Resistant Depression in Adults Executive Summary
Comprtive Effectiveness Review Numer 33 Effective Helth Cre Progrm Nonphrmcologic Interventions for Tretment-Resistnt Depression in Adults Executive Summry Bckground Mjor depressive disorder (MDD) is common
More informationComputer-Aided Learning in Insulin Pump Training
Journl of Dibetes Science nd Technology Volume 4, Issue 4, July 2010 Dibetes Technology Society TECHNOLOGY REPORTS Computer-Aided Lerning in Insulin Pump Trining Sergey V., M.Sc., 1 nd Chrles J. George,
More informationSeasonal influenza vaccination programme country profile: Ireland
Sesonl influenz vccintion progrmme country profile: Irelnd 2012 13 Seson Bckground informtion Influenz immunistion policy nd generl fcts bout Irelnd Volume indices of GDP per cpit in 2011 nd 2013 (EU-
More informationReducing the Risk. Logic Model
Reducing the Risk Logic Model ETR (Eduction, Trining nd Reserch) is nonprofit orgniztion committed to providing science-bsed innovtive solutions in helth nd eduction designed to chieve trnsformtive chnge
More informationHealth-Related Quality of Life and Symptoms of Depression in Extremely Obese Persons Seeking Bariatric Surgery
Oesity Surgery, 15, 3-39 Helth-Relted Qulity of Life nd Symptoms of Depression in Extremely Oese Persons Seeking Britric Surgery Anthony N. Frictore, PhD; Thoms A. Wdden, PhD; Dvid B. Srwer, PhD; Myles
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationDebra A. Ignaut, R.N., B.S., C.D.E., and Haoda Fu, Ph.D.
Journl of Dietes Science nd Technology Volume 6, Issue 2, Mrch 2012 Dietes Technology Society TECHNOLOGY REPORT Comprison of Insulin Diluent Lekge Postinjection Using Two Different Needle Lengths nd Injection
More informationAppendix J Environmental Justice Populations
Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:
More informationbuild Firm, sexy arms
w uild Firm, sexy rms Wnt toned, strong rms tht crown you pushup queen t oot cmp? Wnt to rock tnk top? These four moves re wht you need. Achieve Totl Arm Envy Mny women zero in on the show-off muscles,
More informationBilling and Coding Guide. Hospital Outpatient Department
illing nd oding Guide Hospitl Outptient Deprtment overge, coding, nd pyment in the hospitl outptient deprtment ONPTTRO (ptisirn) received US Food nd Drug dministrtion (FD) pprovl on 10 ug 2018, nd is indicted
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationOptimizing Metam Sodium Fumigation in Fine-Textured Soils
Optimizing Metm Sodium Fumigtion in Fine-Textured Soils Neil C Gudmestd University Distinguished Professor & Endowed Chir of Potto Pthology Deprtment of Plnt Pthology North Dkot Stte University Erly Dying
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationJudges and other legal personnel, understandably, have a
Mentl Helth Review Tribunls in the UK: Applying Therpeutic Jurisprudence Perspective Nicol Ferencz nd Jmes McGuire Judges nd other legl personnel, understndbly, hve profound interest in the impct of their
More informationThe potential future of targeted radionuclide therapy: implications for occupational exposure? P. Covens
The potentil future of trgeted rdionuclide therpy: implictions for occuptionl exposure? Introduction: Trgeted Rdionuclide Therpy (TRT) Systemic tretment Molecule lbelled with rdionuclide delivers toxic
More informationStudy of Stress Distribution in the Tibia During Stance Phase Running Using the Finite Element Method
Ksetsrt J. (Nt. Sci.) 48 : 729-739 (2014) Study of Stress Distriution in the Tii During Stnce Phse Running Using the Finite Element Method Thepwchr Ruchirh 1, Tumrong Puttpitukporn 1, * nd Siriporn Ssimontonkul
More informationStandard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs
Standard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed
More informationPAMPHLET. Texas Veterans Commission. Post-Traumatic (PTSD) Stress Distorder TXD V P /NO.3. No. 3, May/June 2008
TXD V 400.6 P191 2008/NO.3 Texs Veterns Commission PAMPHLET No. 3, My/June 2008 TH NVRIYOF TEXAS-PAN AMERICAN 0 1161 0865 0775 Post-Trumtic Stress Distorder (PTSD) The Texs Veterns Commission does not
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationProvide a Buffet and Carvery Service
CU926 Provide Buffet nd Crvery Servie Unit summry This unit is out prepring the rvery or uffet disply y rrnging items suh s rokery, utlery nd npkins. It lso overs serving ustomers t the rvery or uffet
More informationMeat and Food Safety. B.A. Crow, M.E. Dikeman, L.C. Hollis, R.A. Phebus, A.N. Ray, T.A. Houser, and J.P. Grobbel
Met nd Food Sfety Needle-Free Injection Enhncement of Beef Strip Loins with Phosphte nd Slt Hs Potentil to Improve Yield, Tenderness, nd Juiciness ut Hrm Texture nd Flvor B.A. Crow, M.E. Dikemn, L.C. Hollis,
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationResearch & Development. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff
Department Title of SOP Research & Development Safety reporting SOP SOP reference no: R&D GCP SOP 07 Authors: Current version number and date: J H Pacynko and J Illingworth Version 9, 31.01.18 Next review
More informationDefining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and Practice
Preventing Chronic Disese Defining nd Mesuring Chronic : Impertives fo... Pge 1 of 16 SPECIAL TOPIC Volume 10 April 25, 2013 Defining nd Mesuring Chronic : Impertives for Reserch, Policy, Progrm, nd Prctice
More informationFriendship and Aggressiveness as Determinants of Conflict Outcomes in Middle Childhood
Developmentl Psychology 1989, Vol 25,No.5,8l2-8l9 Copyright 1989 y the Americn Psychologicl Assocition, Inc. 0012-1649/89/S00.75 ship nd Aggressiveness s Determinnts of Conflict Outcomes in Middle Childhood
More informationChapter 2 DEFINITIONS
Humn Alcohol nd Gming Commission of Ontrio 90 Shepprd Avenue Est Suite 200 Toronto ON M2N 0A4 Commission des lcools et des jeux de l Ontrio 90, venue Shepprd Est Bureu 200 Toronto ON M2N 0A4 Ontrio Toll
More informationOregon Individual and Family Plans OREGON APPLICATION AND STANDARD HEALTH STATEMENT
B CDE Regence BlueCross BlueShield of Oregon Oregon Individul nd Fmily Plns Blue Selections Premier Blue Selections Plus Blue Selections Bsic Regence HS Helthpln nd Individul Dentcre OREGON PPLICTION ND
More informationHIV and AIDS: Plan and annual targets
HIV nd AIDS: 0-5 Pln nd nnul trgets Outcome Relevnt CSO nd PLHIV networks effectively coordinte nd prticipte in decision mking for CSOs, including PLHIV Umrell Orgniztions nd Networks effectively representing
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Site Initiation SOP-RES-010 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Rachelle
More informationRestorative planning for hemisection surgery: a technique report
CLINICAL REPORT 215 Sr Tit-Pour, Anthony Roerts, Ro Hrrison, Iin Chpple Restortive plnning for hemisection surgery: technique report KEY WORDS hemisection, lortory stges, restortion Hemisection surgery
More informationRadiographic evaluation of the technical quality of undergraduate endodontic competence cases in the Dublin Dental University Hospital: an audit
Rdiogrphic evlution of the technicl qulity of undergrdute endodontic competence cses in the Dulin Dentl University Hospitl: n udit Précis: An udit exmining the technicl qulity of undergrdute endodontic
More informationManagement and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence
Clinicin Summry Mentl Helth Eting Disorders Mngement nd Outcomes of Binge-Eting Disorder in Adults: Current Stte of the Evidence Focus of This Summry This is summry of systemtic review evluting the evidence
More informationCheck your understanding 3
1 Wht is the difference etween pssive trnsport nd ctive trnsport? Pssive trnsport is the movement of prticles not requiring energy. Movement of prticles in ctive trnsport uses energy. 2 A gs tp in the
More informationRecall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study
Syddnsk Universitet Recll Bis in Childhood Atopic Diseses Among Adults in The Odense Adolescence Cohort Study Mørtz, Chrlotte G; Andersen, Klus Ejner; Bindslev-Jensen, Crsten Published in: Act Dermto-Venereologic
More informationAnnual Progress and Safety Reporting SOP for HEY-sponsored CTIMPs
R&D Department Annual Progress and Safety Reporting SOP for HEY-sponsored CTIMPs Hull and East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationSTANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA
STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED BY THE NNUH and UEA Version 1.0 Version date 13.12.2016 Effective date 13.12.2016 Number of pages 11 pages Review date November
More information2. Hubs and authorities, a more detailed evaluation of the importance of Web pages using a variant of
5 Web Serch Outline: 1. Pge rnk, for discovering the most ëimportnt" pges on the Web, s used in Google. 2. Hubs nd uthorities, more detiled evlution of the importnce of Web pges using vrint of the eigenvector
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationManual of Food Safety Management System, FSS Act, 2006
Mnul of Food Sfety Mngement System, FSS Act, 2006 FSMS Progrm Pge 0 SCOPE OF THIS DOCUMENT Section 16(2)(c), of the FSS Act, 2006 provides for the mechnism for ccredittion of certifiction bodies for Food
More informationThe Quality and Outcomes Framework (QOF) is a pay-for-performance
Effect of UK Py-for-Performnce Progrm on Ethnic Disprities in Dibetes Outcomes: Interrupted Time Series Anlysis Riydh Alshmsn, MSc John Tyu Lee, MSc Azeem Mjeed, MD Goplkrishnn Netuveli, PhD Christopher
More informationSUPPLEMENT TOOL TO SET AND MONITOR TARGETS FOR HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
SUPPLEMENT TOOL TO SET AND MONITOR TARGETS FOR HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS SUPPLEMENT TO THE 2014 CONSOLIDATED GUIDELINES FOR HIV PREVENTION, DIAGNOSIS, TREATMENT
More informationSOME MECHANISTIC CONCEPTS IN ELECTROPHILIC ADDITION REACTIONS TO C=C BONDS
SM MANISTI NPTS IN LTPILI AITIN ATINS T = BNS The = ond is considered to e wek se/nucleophile. The high concentrtion of electron density mkes the pi ond Lewis se, ut in order to donte electrons the pi
More informationResearch Article Patterns of Cancer Genetic Testing: A Randomized Survey of Oregon Clinicians
Hindwi Publishing Corportion Journl of Cncer Epidemiology Volume 2012, Article ID 294730, 11 pges doi:10.1155/2012/294730 Reserch Article Ptterns of Cncer Genetic Testing: A Rndomized Survey of Oregon
More informationSUSPECT ADVERSE REACTION REPORT
CIOMS FORM SUSPECT ADVERSE REACTION REPORT DE-BFARM-16390235 I. REACTION INFORMATION 1. PATIENT INITIALS 1. COUNTRY 2. DATE OF BIRTH 2. AGE 3. SEX 4-6 REACTION ONSET privcy (10000059): Abdominl discomfort
More informationReceiving family physician s advice and the stages of change in smoking cessation among Arab minority men in Israel
Fmily Prctice, 2016, Vol. 33, No. 6, 626 632 doi:10.1093/fmpr/cmw090 Advnce Access puliction 2 Septemer 2016 Epidemiology Receiving fmily physicin s dvice nd the stges of chnge in smoking cesstion mong
More informationGoal: Evaluate plant health effects while suppressing dollar spot and brown patch
Newer Fungicide Products Alone nd In Rottion on Chicgo Golf Green Reserchers: Chicgo District Golf Assoc. Derek Settle, Tim Sibicky, nd Nick DeVries Gol: Evlute plnt helth effects while suppressing dollr
More informationEFFECTS OF AN ACUTE ENTERIC DISEASE CHALLENGE ON IGF-1 AND IGFBP-3 GENE EXPRESSION IN PORCINE SKELETAL MUSCLE
Swine Dy 22 Contents EFFECTS OF AN ACUTE ENTERIC DISEASE CHALLENGE ON IGF-1 AND IGFBP-3 GENE EXPRESSION IN PORCINE SKELETAL MUSCLE B. J. Johnson, J. P. Kyser, J. D. Dunn, A. T. Wyln, S. S. Dritz 1, J.
More informationFactors influencing help seeking in mentally distressed young adults: a cross-sectional survey
L Biddle, D Gunnell, D Shrp nd J L Donovn Fctors influencing help seeking in mentlly distressed young dults: cross-sectionl survey Lucy Biddle, Dvid Gunnell, Debbie Shrp nd Jenny L Donovn SUMMARY Bckground:
More informationP AND K IN POTATOES. Donald A Horneck Oregon State University Extension Service
P AND K IN POTATOES Donld A Hornek Oregon Stte University Extension Servie INTRODUCTION Phosphorous nd potssium re importnt to grow high yielding nd qulity pottoes. Muh of the northwest hs hd trditionlly
More informationEstimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain
Rpid communictions Estimting the impct of the influenz pndemic on mortlity in the elderly in Nvrre, Spin J Cstill (jcstilc@nvrr.es) 1, J Etxeberri 1, E Ardnz 1, Y Floristán 1, R López Escudero 1, M Guevr
More informationReview article. Key words non specific low back pain, exercise therapy, stretching, motor control. Grade D
Spinl Surgery 31 2 140 144 2017 総説 Review rticle Astrct Exercise therpy is useful for low ck pin. Exercise therpy ims to improve posturl lignment, muscle strength, nd endurnce, nd lso contriutes to pin
More informationEffects of physical exercise on working memory and prefrontal cortex function in post-stroke patients
Effects of physicl exercise on working memory nd prefrontl cortex function in post-stroke ptients M Moriy, C Aoki, K Sktni Grdute School of Helth Sciences Reserch, Mjor of Physicl Therpy, TeikyoHeisei
More informationThe Acute Time Course of Concurrent Activation Potentiation
Mrquette University e-publictions@mrquette Exercise Science Fculty Reserch nd Publictions Exercise Science, Deprtment of 1-1-2010 The Acute Time Course of Concurrent Activtion Potentition Luke Grceu Mrquette
More informationOverview of the Immune System in Transplantation
Helthline VOLUME 9 Corm * Continuing Eduction Progrm Overview of the Immune System in Trnsplnttion The immune system is complex, interctive nd essentil for survivl. In trnsplnt, however, some of the ody
More informationEpidemiology of the Viral Hepatitis-HIV Syndemic in San Francisco: A Collaborative Surveillance Approach
Dt Hrmoniztion nd Registry Mtching Epidemiology of the Virl Heptitis-HIV Syndemic in Sn Frncisco: A Collbortive Surveillnce Approch Meliss A. Snchez, PhD, MA Susn Scheer, PhD, MPH b Sue Shllow, MPH, CACLS
More informationTHE EFFECT OF DIFFERENT STIMULI ON MEAGRE (Argyrosomus regius) FEEDING BEHAVIOUR.
THE EFFECT OF DIFFERENT STIMULI ON MEGRE (rgyrosomus regius) FEEDING EHVIOUR. Ionnis E. Ppdkis, Nikos Ppndroulkis, lkioni Sfendourki, Veronic Cmporesi 3, Mnolis Vsilkis, Constntinos C. Mylons Institute
More informationMETHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY
METHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY 1.0 SCOPE AND APPLICATION 1.1 Method 4010 is procedure for screening solids such s soils, sludges, nd queous medi such s wste wter nd lechtes
More informationHealth Coaching: A Preliminary Report on the Effects in Traumatic Brain Injury/Polytrauma Patients
ORIGINAL RESEARCH Helth Coching: A Preliminry Report on the Effects in Trumtic Brin Injury/Polytrum Ptients Esmerld Mdrigl, MSW; Mx Gry, BA; Molly A. Timmermn, DO; Ttin Orozco, PhD; Dine Cowper Ripley,
More informationJ Arab Soc Med Res 9: The Arab Society for Medical Research
6 Originl rticle Assessment of complince to stndrd precutions mong surgeons in Zgzig University Hospitls, Egypt, using the Helth Belief Model Emn M. Mortd, Mrw M. Zlt b Deprtments of C ommunity Medicine
More informationBioactive milk components to secure growth and gut development in preterm pigs ESTER ARÉVALO SUREDA PIGUTNET FA1401 STSM
Bioctive milk components to secure growth nd gut development in preterm pigs ESTER ARÉVALO SUREDA PIGUTNET FA1401 STSM STSM Pigutnet FA1401 STSM 03/Septemer 30/Novemer/2017 (3 months) Host: Home: Thoms
More information3. DRINKING WATER INTAKE BACKGROUND KEY GENERAL POPULATION STUDIES ON DRINKING WATER INTAKE RELEVANT GENERAL POPULATION
3. DRINKING WATER INTAKE...1 3.1. BACKGROUND...1 3.2. KEY GENERAL POPULATION STUDIES ON DRINKING WATER INTAKE 1 3.3. RELEVANT GENERAL POPULATION STUDIES ON DRINKING WATER INTAKE...9 3.4. PREGNANT AND LACTATING
More informationCode of Conduct. Date of Issue: May 2016
INTERNATIONAL HOCKEY FEDERATION POLICIES AND PROCEDURES Coe of Conuct Dte of Issue: My 2016 1. PURPOSE, SCOPE AND APPLICATION 1.1 The Interntionl Hockey Feertion (FIH) is recognise y the Interntionl Olympic
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationMaximize Your Genetic Return. Find your Genetic Solution with Boviteq West
Mximize Your Genetic Return. Find your Genetic Solution with Boviteq West Boviteq West is comprehensive reproductive solutions provider, imed t finding the right genetic solution for every niml nd every
More informationResults of the Tokyo Consensus Meeting Tokyo Guidelines
J Heptobiliry Pncret Surg (2007) 14:114 121 DOI 10.1007/s00534-006-1163-8 Results of the Tokyo Consensus Meeting Tokyo Guidelines Toshihiko Myumi 1, Tdhiro Tkd 2, Yoshifumi Kwrd 3, Yuji Nimur 4, Mshiro
More informationTeacher motivational strategies and student self-determination in physical education
Loughborough University Institutionl Repository Techer motivtionl strtegies nd student self-determintion in physicl eduction This item ws submitted to Loughborough University's Institutionl Repository
More informationSEIZURES AND EPILEPSY
SEIZURES AND EPILEPSY CONTENT CREATED BY Lern more t www.helth.hrvrd.edu TALK WITH YOUR DOCTOR Tble of Contents WHAT IS A SEIZURE? 4 WHAT IS EPILEPSY? 6 TESTING 7 TREATMENT OPTIONS 9 ANTI-SEIZURE MEDICATION
More informationChilblains (pernio, perniosis) are cold-induced, painful or itching
Nifedipine vs Plcebo for Tretment of Chronic Chilblins: A Rndomized Controlled Tril Ibo H. Souwer, MD 1 Jcobus H. J. Bor, BSc (Mth) 2 Pul Smits, MD, PhD 3 Antoine L. M. Lgro-Jnssen, MD, PhD 1 1 Deprtment
More informationPhysicians prescribing a new medication often fail to discuss basic. Intervention to Enhance Communication About Newly Prescribed Medications
to Enhnce Communiction About Newly Prescribed Medictions Derjung M. Trn, MD, PhD 1 Debor A. Pterniti, PhD 2 Deborh K. Orosz, BA 3 Chi-Hong Tseng, PhD 4 Neil S. Wenger, MD, MPH 4 1 Deprtment of Fmily Medicine,
More informationEstimating the Cost to U.S. Health Departments to Conduct HIV Surveillance
Reserch Articles Estimting the Cost to U.S. Helth Deprtments to Conduct HIV Surveillnce Rm K. Shresth, PhD Stephnie L. Snsom, PhD, MPP, MPH Benjmin T. Lffoon, BS Pul G. Frnhm, PhD R. Luke Shouse, MD Kren
More informationA Study of Serological Markers of Hepatitis B and C Viruses in Istanbul, Turkey
Originl Pper Med Princ Prct 2003;12:184 188 DOI: 10.1159/000070757 Received: Decemer 15, 2001 Revised: Decemer 21, 2002 A Study of Serologicl Mrkers of Heptitis B nd C Viruses in Istnul, Turkey S. Erden
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationDetecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool. Rodolfo Valdez, Ph.D.
Journl of Dietes Science nd Technology Volume 3, Issue 4, July 2009 Dietes Technology Society SYMPOSIUM Detecting Undignosed Type 2 Dietes: Fmily History s Risk Fctor nd Screening Tool Rodolfo, Ph.D. Astrct
More informationPreliminary Findings of a Randomized Controlled Trial of an Interdisciplinary Military Pain Program
MILITARY MEDICINE, 174, 3:270, 2009 Preliminry Findings of Rndomized Controlled Tril of n Interdisciplinry Militry Pin Progrm Robert J. Gtchel, PhD * ; Donld D. McGery, PhD ; Aln Peterson, PhD ; Mysti
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationPrime Enrollees Consumer Watch NHC Patuxent River FY 2016 Defense Health Cost Assessment & Program Evaluation
Prime Enrollees Consumer Wtch NHC Ptuxent River 16 Defense Helth Cost Assessment & Progrm Evlution NHC Ptuxent River: Smple size-1,457 Response rte-1.2% Source: Helth Cre Survey of DoD Beneficiries Inside
More informationHow Do Emergency Physicians Interpret Prescription Narcotic History When Assessing Patients Presenting to the Emergency Department with Pain?
credits ville for this rticle see pge 80. How Do Emergency Physicins Interpret Prescription Nrcotic History When Assessing Ptients Presenting to the Emergency Deprtment with Pin? y A Grover, MD; Gus M
More informationURINARY incontinence is an important and common
Urinry incontinence in older people in the community: neglected problem? Helen Stoddrt, Jenny Donovn, Elise Whitley, Deborh Shrp nd In Hrvey SUMMARY Bckground: The prevlence nd impct of urinry incontinence
More informationDifferent type 2 diabetes risk assessments predict dissimilar numbers at high risk :
Reserch Benjmin J Gry, Richrd M Brcken, Dniel Turner, Kerry Morgn, Michel Thoms, Slly P Willims, Meurig Willims, Sm Rice nd Jeffrey W Stephens on behlf of the Prosiect Sir Gâr Group Different type 2 dibetes
More informationInadequate health literacy is a
Testing the BRIEF Helth Litercy Screening Tool Jolie Hun, PhD, Virgini Nolnd-Dodd, PhD, MPH, Jill Vrnes, EdD, John Grhm-Pole, MD, Brbr Rienzo, PhD, nd Ptrici Donldson, RN Due to the oppressive strins lid
More information